Wednesday, 30 Aug 2023 | Funding Deadline
The Health Technology Assessment (HTA) Programme funds research about the clinical and cost-effectiveness, and broader impact of healthcare treatments and tests, for those who plan, provide or receive care from NHS, and social care services.
The frequency of bone metastasis is on the rise as cancer incidence increases and survival improves. Together, bone metastases and their associated complications have serious negative consequences for patients and result in a high economic burden for the healthcare system. This calls for research to identify better treatment approaches and improve the management of SREs.
The HTA Programme is accepting Stage 1 applications to their commissioned workstream for this primary research or evidence synthesis topic.
Deadline for proposals: 30 August 2023
Find out more here